Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-γ-knockout mice

Circulation

Volumn 110, Issue 18, 2004, Pages 2910-2917

  Afanasyeva, Marina ^a,b   Georgakopoulos, Dimitrios ^a,b   Fairweather, DeLisa ^a   Caturegli, Patrizio ^a   Kass, David A ^a   Rose, Noel R ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cardiac output; Hemodynamics; Inflammation; Myocarditis; Pressure volume relation

Indexed keywords

CARDIAC MYOSIN; GAMMA INTERFERON;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEMODYNAMICS; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; MYOCARDITIS; NONHUMAN; PHENOTYPE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNE DISEASES; CARDIAC OUTPUT, LOW; DIASTOLE; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HEART VENTRICLES; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDITIS; ORGAN SIZE; PERICARDITIS, CONSTRICTIVE; PHENOTYPE; PRESSURE; STROKE VOLUME; WEIGHT LOSS;

EID: 8144226104     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000147538.92263.3A     Document Type: Article

References (22)

1. Kabbani SS, LeWinter MM. Pericardial diseases. Curr Treat Options Cardiovasc Med. 2002;4:487-495.
2. Ling LH, Oh JK, Schaff HV, et al. Constructive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380-1386.
3. Kabbani SS, LeWinter MM. Diastolic heart failure: constrictive, restrictive, and pericardial. Cardiol Clin. 2000;18:501-509.
4. Shiverick KL, Thomas LL, Alpert NR. Purification of cardiac myosin: application to hypertrophied myocardium. Biochim Biophys Acta. 1975;393:124-133.
5. Georgakopoulos D, Kass D. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. J Physiol. 2001;534:535-545.
6. Matsubara H, Takaki M, Yasuhara S, et al. Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle: better alternative to exponential time constant. Circulation. 1995;92:2318-2326.
7. Afanasyeva M, Wang Y, Kaya Z, et al. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol. 2001;159:193-203.
8. Afanasyeva M, Wang Y, Kaya Z, et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation. 2001;104:3145-3151.
9. Little WC, Ohno M, Kitzman DW, et al. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation. 1995;92:1933-1939.
10. Matsumori A, Kawai C. Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle. J Pathol. 1980;131:97-106.
11. Leak LV, Ferrans VJ, Cohen SR, et al. Animal model of acute pericarditis and its progression to pericardial fibrosis and adhesions: ultrastructural studies. Am J Anat. 1987;180:373-390.
12. Kulkarni AB, Ward JM, Yaswen L, et al. Transforming growth factor-beta 1 null mice: an animal model for inflammatory disorders. Am J Pathol. 1995;146:264-275.
13. Page PL, Plumb VJ, Okumura K, et al. A new animal model of atrial flutter. J Am Coll Cardiol. 1986;8:872-879.
14. Loging JA, New RB, Baicu SC, et al. Effects of angiotensin type-I receptor blockade on pericardial fibrosis. J Surg Res. 1999;87:101-107.
15. Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852-1857.
16. Kalra S, Utz JP, Ryu JH. Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis. Mayo Clin Proc. 2003;78:1082-1087.
17. Chiaramonte MG, Cheever AW, Malley JD, et al. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology. 2001;34:273-282.
18. Ong C, Wong C, Roberts CR, et al. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur J Immunol. 1998;28:2619-2629.
19. Atamas SP, Luzina IG, Dai H, et al. Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J Immunol. 2002;168:1139-1145.
20. Duncan MR, Berman B. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med. 1985;162:516-527.
21. Ando M, Miyazaki E, Fukami T, et al. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study. Respirology. 1999;4:383-391.
22. Seward JB, Tajik AJ. Primary cardiomyopathies: classification, pathophysiology, clinical recognition and management. Cardiovasc Clin. 1980;10:199-230.